Raymond James Financial Inc Altimmune, Inc. Transaction History
Raymond James Financial Inc
- $258 Billion
- Q1 2025
A detailed history of Raymond James Financial Inc transactions in Altimmune, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 14,660 shares of ALT stock, worth $83,708. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,660
Previous 12,240
19.77%
Holding current value
$83,708
Previous $88,000
17.05%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ALT
# of Institutions
203Shares Held
37.6MCall Options Held
2MPut Options Held
1.69M-
Black Rock Inc. New York, NY5.32MShares$30.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.41MShares$25.2 Million0.0% of portfolio
-
State Street Corp Boston, MA3.39MShares$19.4 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.75MShares$15.7 Million0.89% of portfolio
-
Geode Capital Management, LLC Boston, MA1.71MShares$9.74 Million0.0% of portfolio
About Altimmune, Inc.
- Ticker ALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,025,300
- Market Cap $280M
- Description
- Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...